Header Logo

CINDY L SCHWARTZ

TitleProfessor
InstitutionMD Anderson
DepartmentPediatrics
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lo AC, Liu A, Liu Q, Yasui Y, Castellino SM, Kelly KM, Hererra AF, Friedberg JW, Friedman DL, Schwartz CL, Pei Q, Kessel S, Bergeron-Gravel S, Dama H, Roberts K, Constine LS, Hodgson DC. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. JAMA Netw Open. 2024 Jan 02; 7(1):e2351062. PMID: 38241048; PMCID: PMC10799264.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Chow EJ, Aggarwal S, Doody DR, Aplenc R, Armenian SH, Baker KS, Bhatia S, Blythe N, Colan SD, Constine LS, Freyer DR, Kopp LM, Laverdi?re C, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Lipshultz SE. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 04 20; 41(12):2248-2257. PMID: 36669148; PMCID: PMC10448941.
      Citations: 1     Fields:    Translation:Humans
    3. Werk RS, Koyama T, Sun L, Wolden S, Kelly KM, Constine LS, Schwartz CL, Friedman DL. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031. J Adolesc Young Adult Oncol. 2023 Jun; 12(3):359-365. PMID: 36094417; PMCID: PMC10282797.
      Citations:    
    4. Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS. Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. Blood. 2022 09 08; 140(10):1086-1093. PMID: 35763667; PMCID: PMC9461469.
      Citations:    
    5. Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM. Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev. 2022 Mar 01; 31(3):536-542. PMID: 34810210; PMCID: PMC9067064.
      Citations: 1     Fields:    Translation:Humans
    6. Johnston RL, Mottok A, Chan FC, Jiang A, Diepstra A, Visser L, Gascoyne RD, Friedman DL, Schwartz CL, Kelly KM, Scott DW, Horton TM, Steidl C, Telenius A. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022 02 10; 139(6):889-893. PMID: 34662378; PMCID: PMC8832480.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Kahn JM, Pei Q, Friedman DL, Kaplan J, Keller FG, Hodgson D, Wu Y, Appel BE, Bhatia S, Henderson TO, Schwartz CL, Kelly KM, Castellino SM. Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials. Lancet Haematol. 2022 Jan; 9(1):e49-e57. PMID: 34971582; PMCID: PMC8815096.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    8. Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):890-900. PMID: 34767937; PMCID: PMC9038118.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    9. Chow EJ, Aplenc R, Vrooman LM, Doody DR, Huang YV, Aggarwal S, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Asselin BL, Schwartz CL, Lipshultz SE. Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group. Cancer. 2022 02 15; 128(4):788-796. PMID: 34644414; PMCID: PMC8792306.
      Citations: 1     Fields:    Translation:Humans
    10. Milgrom SA, Kim J, Chirindel A, Kim J, Pei Q, Chen L, Buxton A, Kessel S, Leal J, McCarten KM, Hoppe BS, Wolden SL, Schwartz CL, Friedman DL, Kelly KM, Cho SY. Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031. Pediatr Blood Cancer. 2021 09; 68(9):e29212. PMID: 34245210; PMCID: PMC8809108.
      Citations: 2     Fields:    Translation:Humans
    11. Giulino-Roth L, Pei Q, Buxton A, Bush R, Wu Y, Wolden SL, Constine LS, Kelly KM, Schwartz CL, Friedman DL. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group. Blood. 2021 03 18; 137(11):1449-1456. PMID: 33512412; PMCID: PMC7976513.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    12. Weisman AJ, Kim J, Lee I, McCarten KM, Kessel S, Schwartz CL, Kelly KM, Jeraj R, Cho SY, Bradshaw TJ. Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients. EJNMMI Phys. 2020 Dec 14; 7(1):76. PMID: 33315178; PMCID: PMC7736382.
      Citations: 3     
    13. Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE, Children?s Oncology Group. Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. Cardiooncology. 2019; 5:15. PMID: 32154021; PMCID: PMC7048050.
      Citations: 8     
    14. Kahn JM, Kelly KM, Pei Q, Bush R, Friedman DL, Keller FG, Bhatia S, Henderson TO, Schwartz CL, Castellino SM. Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study. J Clin Oncol. 2019 11 10; 37(32):3009-3017. PMID: 31539308; PMCID: PMC6839907.
      Citations: 11     Fields:    Translation:Humans
    15. Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C. Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group. Br J Haematol. 2019 10; 187(1):39-48. PMID: 31180135; PMCID: PMC6857800.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    16. Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Capra M, Dhooge C, Eriksson M, Flanagan AM, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kager L, von Kalle T, Kabickova E, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Sydes MR, Marina N, Smeland S, Calaminus G, Friedel G, K?hne T, Lang S, Mayer-Steinacker R, Timmermann B. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50. PMID: 30685685; PMCID: PMC6506906.
      Citations: 121     Fields:    Translation:HumansCTClinical Trials
    17. Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2019 01; 66(1):e27444. PMID: 30255612; PMCID: PMC6249072.
      Citations: 11     Fields:    Translation:Humans
    18. Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 12; 65(12):e27375. PMID: 30277639; PMCID: PMC6192844.
      Citations: 3     Fields:    Translation:Humans
    19. Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM. Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. Blood. 2018 09 13; 132(11):1208-1211. PMID: 30061157; PMCID: PMC6137557.
      Citations: 3     Fields:    Translation:Humans
    20. McCarten KM, Metzger ML, Drachtman RA, Pei Q, Friedman DL, Schwartz CL, Kelly KM. Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. Pediatr Radiol. 2018 11; 48(12):1736-1744. PMID: 30014200; PMCID: PMC6208959.
      Citations: 8     Fields:    Translation:Humans
    21. Keller FG, Castellino SM, Chen L, Pei Q, Voss SD, McCarten KM, Senn SL, Buxton AB, Bush R, Constine LS, Schwartz CL. Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. Cancer. 2018 08 01; 124(15):3210-3219. PMID: 29738613; PMCID: PMC6097921.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    22. Aldrink JH, Appel B, Kaplan JA, Hutchison RE, Schwartz CL, Kelly KM, McCarten K, Ehrlich PF. Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2018 04; 40(3):246-247. PMID: 29401099; PMCID: PMC5866194.
      Citations: 1     Fields:    Translation:Humans
    23. Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan KV, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA. Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031. Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1119-1125. PMID: 29722656; PMCID: PMC6555555.
      Citations: 1     Fields:    Translation:Humans
    24. Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Cancer. 2018 01 01; 124(1):136-144. PMID: 28902390; PMCID: PMC5735034.
      Citations: 14     Fields:    Translation:Humans
    25. Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE. Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 Jan; 65(1). PMID: 28802087; PMCID: PMC5699946.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    26. Schwartz CL, Chen L, Constine LS, Chauvenet A, Fern?ndez KS, de Alarc?n PA. Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report. Pediatr Blood Cancer. 2017 Dec; 64(12). PMID: 28612375; PMCID: PMC5799083.
      Citations: 5     Fields:    Translation:Humans
    27. Esbenshade AJ, Zhao Z, Aftandilian C, Saab R, Wattier RL, Beauchemin M, Miller TP, Wilkes JJ, Kelly MJ, Fernbach A, Jeng M, Schwartz CL, Dvorak CC, Shyr Y, Moons KGM, Sulis ML, Friedman DL. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia. Cancer. 2017 Oct 01; 123(19):3781-3790. PMID: 28542918; PMCID: PMC5610619.
      Citations: 3     Fields:    Translation:HumansCells
    28. Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Ader J, Diller L, Schwartz CL. Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017 Oct; 64(10). PMID: 28453181.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    29. Welch JJG, Schwartz CL, Higman M, Chen L, Buxton A, Kanakry JA, Kahwash SB, Hutchison RE, Friedman DL, Ambinder RF. Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma. Blood Adv. 2017 Apr 25; 1(11):681-684. PMID: 29296710; PMCID: PMC5727814.
      Citations: 13     Fields:    
    30. Harrison DJ, Schwartz CL. Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. Curr Treat Options Oncol. 2017 04; 18(4):24. PMID: 28391422.
      Citations: 21     Fields:    Translation:Humans
    31. Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC, Charpentier AM. Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):943-950. PMID: 27869096; PMCID: PMC5584603.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    32. Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL. Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey. Cancer. 2017 03 01; 123(5):869-878. PMID: 27859009.
      Citations: 21     Fields:    Translation:Humans
    33. Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 04; 64(4). PMID: 27786406; PMCID: PMC5702912.
      Citations: 11     Fields:    Translation:Humans
    34. Marina NM, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brown KLB, Butterfass-Bahloul T, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hawkins DS, Hogendoorn PCW, Isakoff MS, Janeway KA, Kager L, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Sydes MR, Whelan JS, Smeland S, Brichard B, Calaminus G, Hardes J, Helmke K, J?rgens H, K?hne T, Reichardt P, Werner M. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. PMID: 27569442; PMCID: PMC5052459.
      Citations: 131     Fields:    Translation:HumansCTClinical Trials
    35. Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL. Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group. J Clin Oncol. 2016 07 10; 34(20):2372-9. PMID: 27185849; PMCID: PMC4981978.
      Citations: 12     Fields:    Translation:Humans
    36. Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 10; 63(10):1737-43. PMID: 27128693; PMCID: PMC5136499.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    37. Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61. PMID: 26398490; PMCID: PMC4779061.
      Citations: 26     Fields:    Translation:Humans
    38. Macpherson CF, Hooke MC, Friedman DL, Campbell K, Withycombe J, Schwartz CL, Kelly K, Meza J. Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group. J Adolesc Young Adult Oncol. 2015 Sep; 4(3):137-40. PMID: 26421221; PMCID: PMC4575513.
      Citations: 2     Fields:    Translation:Humans
    39. Mauz-K?rholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, K?rholz D. Pediatric Hodgkin Lymphoma. J Clin Oncol. 2015 Sep 20; 33(27):2975-85. PMID: 26304892.
      Citations: 35     Fields:    Translation:Humans
    40. Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH. Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group. J Clin Oncol. 2015 Aug 20; 33(24):2639-45. PMID: 26014292; PMCID: PMC4534526.
      Citations: 26     Fields:    Translation:Humans
    41. Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, Mrazek MD, Agrawal N, Wu MF, Liu H, De Alarcon PA, Trippet TM, Schwartz CL, L?pez-Terrada D. A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study. Br J Haematol. 2015 Jul; 170(1):118-22. PMID: 25833390; PMCID: PMC4478135.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    42. Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL. Radiotherapy quality assurance report from children's oncology group AHOD0031. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1065-71. PMID: 25670539; PMCID: PMC5240783.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    43. Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL. Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2015 May 01; 92(1):60-6. PMID: 25542311; PMCID: PMC4395527.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    44. Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. J Clin Oncol. 2014 Nov 10; 32(32):3651-8. PMID: 25311218; PMCID: PMC4220044.
      Citations: 65     Fields:    Translation:HumansCTClinical Trials
    45. Trippett TM, Schwartz CL, Guillerman RP, Gamis AS, Gardner S, Hogan S, London WB, Chen L, de Alarcon P. Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. Pediatr Blood Cancer. 2015 Jan; 62(1):60-4. PMID: 25308760; PMCID: PMC4465390.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    46. Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatr Blood Cancer. 2014 Sep; 61(9):1558-64. PMID: 24753182; PMCID: PMC4288578.
      Citations: 12     Fields:    Translation:Humans
    47. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2014 Jul; 61(7):1305-12. PMID: 24616347.
      Citations: 3     Fields:    Translation:Humans
    48. Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study. Pediatr Blood Cancer. 2014 Apr; 61(4):749-52. PMID: 24178953; PMCID: PMC3946315.
      Citations: 4     Fields:    Translation:Humans
    49. Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, Schwartz C, Chauvenet A, de Alarc?n PA. Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Dec 15; 59(7):1259-65. PMID: 22911615; PMCID: PMC3468662.
      Citations: 27     Fields:    Translation:Humans
    50. Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jul 20; 30(21):2635-40. PMID: 22689804; PMCID: PMC4559601.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    51. Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. Cancer. 2012 Sep 15; 118(18):4597-605. PMID: 22252521; PMCID: PMC4008337.
      Citations: 65     Fields:    Translation:Humans
    52. Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE, Laverdi?re C. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. Eur J Cancer. 2011 Jun; 47(9):1373-9. PMID: 21514146; PMCID: PMC3736806.
      Citations: 44     Fields:    Translation:Humans
    53. Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL. The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1062-6. PMID: 21910208.
      Citations: 10     Fields:    Translation:Humans
    54. Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Schwartz CL. Early [?8F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. Pediatr Hematol Oncol. 2010 Nov; 27(8):650-7. PMID: 20863157; PMCID: PMC3083978.
      Citations: 1     Fields:    Translation:Humans
    55. Loeb DM, Hobbs RF, Okoli A, Chen AR, Cho S, Srinivasan S, Sgouros G, Shokek O, Wharam MD, Scott T, Schwartz CL. Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. Cancer. 2010 Dec 01; 116(23):5470-8. PMID: 20715156; PMCID: PMC2991401.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    56. Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S. Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):315-6. PMID: 20394859; PMCID: PMC2908913.
      Citations: 6     Fields:    Translation:Humans
    57. Kelly MJ, Vivier PM, Panken TM, Schwartz CL. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer. 2010 Jan; 54(1):83-7. PMID: 19774640.
      Citations: 6     Fields:    Translation:HumansCells
    58. Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia. 2010 Feb; 24(2):320-34. PMID: 20016537; PMCID: PMC2820141.
      Citations: 95     Fields:    Translation:HumansCTClinical Trials
    59. Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE, Laverdi?re C. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood. 2010 Feb 18; 115(7):1351-3. PMID: 20007809; PMCID: PMC2826760.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    60. Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009 Sep 03; 114(10):2051-9. PMID: 19584400; PMCID: PMC2744567.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    61. Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD, Scott T, Schwartz CL. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer. 2009 Jun 01; 115(11):2514-22. PMID: 19338063; PMCID: PMC2974628.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    62. Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM. Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. J Clin Oncol. 2009 Mar 20; 27(9):1456-61. PMID: 19224841; PMCID: PMC2668553.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    63. Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):34-40. PMID: 18722264; PMCID: PMC3532026.
      Citations: 15     Fields:    Translation:Humans
    64. Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N. Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):24-33. PMID: 18722263; PMCID: PMC3531236.
      Citations: 38     Fields:    Translation:Humans
    65. Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. Pediatr Blood Cancer. 2008 Mar; 50(3):667-70. PMID: 17318876.
      Citations: 7     Fields:    Translation:Humans
    66. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008 Feb 01; 26(4):633-8. PMID: 18235123.
      Citations: 263     Fields:    Translation:Humans
    67. Terlou A, Ruble K, Stapert AF, Chang HC, Rowe PC, Schwartz CL. Orthostatic intolerance in survivors of childhood cancer. Eur J Cancer. 2007 Dec; 43(18):2685-90. PMID: 17689953.
      Citations:    Fields:    Translation:Humans
    68. Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother. 2007 Oct; 51(10):3714-9. PMID: 17638696; PMCID: PMC2043253.
      Citations: 40     Fields:    Translation:Humans
    69. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007 Sep 01; 25(25):3991-4008. PMID: 17577017.
      Citations: 259     Fields:    Translation:Humans
    70. Mahone EM, Prahme MC, Ruble K, Mostofsky SH, Schwartz CL. Motor and perceptual timing deficits among survivors of childhood leukemia. J Pediatr Psychol. 2007 Sep; 32(8):918-25. PMID: 17522113.
      Citations: 8     Fields:    Translation:Humans
    71. Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P, Children's Oncology Group. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. J Clin Oncol. 2007 May 20; 25(15):2057-62. PMID: 17513810.
      Citations: 44     Fields:    Translation:Humans
    72. Ehrlich PF, Friedman DL, Schwartz CL, Children Oncology Group Hodgkin Lymphoma study section. Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study. J Pediatr Surg. 2007 May; 42(5):788-91. PMID: 17502184.
      Citations: 2     Fields:    Translation:Humans
    73. Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. J Clin Oncol. 2007 Feb 10; 25(5):493-500. PMID: 17290056.
      Citations: 150     Fields:    Translation:Humans
    74. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006 Oct 12; 355(15):1572-82. PMID: 17035650.
      Citations: 1185     Fields:    Translation:Humans
    75. Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2006 Jun; 28(6):362-8. PMID: 16794504.
      Citations: 23     Fields:    Translation:Humans
    76. Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL. APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. Pediatr Blood Cancer. 2006 Mar; 46(3):320-4. PMID: 16200630.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    77. Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005 Nov; 49(11):4536-45. PMID: 16251293; PMCID: PMC1280172.
      Citations: 59     Fields:    Translation:Humans
    78. Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother. 2005 Aug; 49(8):3317-24. PMID: 16048942; PMCID: PMC1196271.
      Citations: 60     Fields:    Translation:HumansCTClinical Trials
    79. Schwartz CL. Special issues in pediatric Hodgkin's disease. Eur J Haematol Suppl. 2005 Jul; (66):55-62. PMID: 16007870.
      Citations: 7     Fields:    Translation:Humans
    80. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005 Mar 20; 23(9):2004-11. PMID: 15774791.
      Citations: 253     Fields:    Translation:HumansCTClinical Trials
    81. Schwartz CL. Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study. J Pediatr. 2004 Mar; 144(3):407-8. PMID: 15032224.
      Citations:    Fields:    
    82. Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003 Nov 15; 9(15):5442-53. PMID: 14654523.
      Citations: 74     Fields:    Translation:Humans
    83. Schwartz CL. Health status of childhood cancer survivors: cure is more than the eradication of cancer. JAMA. 2003 Sep 24; 290(12):1641-3. PMID: 14506124.
      Citations: 3     Fields:    Translation:Humans
    84. Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol. 2003 Jul; 13(3):346-56. PMID: 12903022.
      Citations: 59     Fields:    Translation:HumansPHPublic Health
    85. Welsh JS, Thurman SA, Borzillary S, Schwartz CL, Howard SP. Sm-153 EDTMP for recurrent metastatic osteosarcoma. Clin Adv Hematol Oncol. 2003 Mar; 1(3):181-3; discussion 183. PMID: 16224400.
      Citations: 2     Fields:    Translation:Humans
    86. Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. J Med Virol. 2002 Nov; 68(3):370-7. PMID: 12226824.
      Citations: 5     Fields:    Translation:HumansCells
    87. Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol. 2002 Jan 15; 20(2):426-33. PMID: 11786570.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    88. Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, Sallan SE. Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol. 2001 Feb 15; 19(4):1040-6. PMID: 11181667.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    89. Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD, Arndt C, Anderson JR, Crist WM, Paidas C, Wiener E, Andrassy RJ, Schwartz CL. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 2000 Feb; 35(2):309-16. PMID: 10693686.
      Citations: 24     Fields:    Translation:Humans
    90. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999 Mar 11; 340(10):764-71. PMID: 10072411.
      Citations: 225     Fields:    Translation:HumansCTClinical Trials
    91. Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist. 1999; 4(1):45-54. PMID: 10337370.
      Citations: 43     Fields:    Translation:Humans
    92. Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, McMannis JD, Kastan MB, Civin CI. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9. PMID: 9849694.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    93. Schwartz CL. Late effects of treatment in long-term survivors of cancer. Cancer Treat Rev. 1995 Jul; 21(4):355-66. PMID: 7585660.
      Citations: 5     Fields:    Translation:Humans
    94. Rosier RN, Teot LA, Hicks DG, Schwartz C, O'Keefe RJ, Puzas JE. Multiple drug resistance in osteosarcoma. Iowa Orthop J. 1995; 15:66-73. PMID: 7634047; PMCID: PMC2329065.
      Citations: 4     Fields:    Translation:HumansCells
    95. Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB. Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J Clin Oncol. 1993 Oct; 11(10):1906-10. PMID: 8410117.
      Citations: 17     Fields:    Translation:Humans
    96. Wang N, Cedrone E, Dry J, Skuse GR, Schwartz C, Terryberry S. Transposition of the oncogene ets-1 in t(11;19) translocation in acute leukemia. Cancer Genet Cytogenet. 1990 Dec; 50(2):199-205. PMID: 2265401.
      Citations:    Fields:    Translation:HumansCells
    97. Schwartz CL. Creating life on the plateau: reproductive potential in survivors of childhood Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1990 Oct; 19(4):1099-100. PMID: 2211248.
      Citations: 1     Fields:    Translation:Humans
    98. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990 Sep; 8(9):1591-7. PMID: 2202792.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    99. Hobbie WL, Schwartz CL. Endocrine late effects among survivors of cancer. Semin Oncol Nurs. 1989 Feb; 5(1):14-21. PMID: 2646663.
      Citations:    Fields:    Translation:HumansPHPublic Health
    100. Henrickson KJ, Powell KR, Schwartz CL. A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities. J Infect Dis. 1988 Mar; 157(3):600-1. PMID: 3343531.
      Citations: 4     Fields:    Translation:HumansCells
    101. Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. J Clin Oncol. 1987 Dec; 5(12):1900-11. PMID: 3500279.
      Citations:    Fields:    Translation:HumansCells
    102. Noga SJ, Schwartz CL, Civin CI, Loken M, Donnenberg AD. Rapid separation of whole human bone marrow aspirates by counterflow centrifugation elutriation. Transplantation. 1987 Mar; 43(3):438-40. PMID: 3547800.
      Citations:    Fields:    Translation:HumansCells
    103. Noga SJ, Cremo CA, Duff SC, Schwartz CL, Melaragno A, Civin CI, Donnenberg AD. Large scale separation of human bone marrow by counterflow centrifugation elutriation. J Immunol Methods. 1986 Sep 27; 92(2):211-8. PMID: 2944969.
      Citations: 2     Fields:    Translation:HumansCells
    104. Noga SJ, Donnenberg AD, Schwartz CL, Strauss LC, Civin CI, Santos GW. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. Transplantation. 1986 Feb; 41(2):220-9. PMID: 2935979.
      Citations: 4     Fields:    Translation:HumansCells
    105. Schwartz CL, Bender KS, Burke PJ, Kan JS, Civin CI. QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine. Cancer Treat Rep. 1984 Jul-Aug; 68(7-8):1043-4. PMID: 6547639.
      Citations: 1     Fields:    Translation:Humans
    106. Mental distress and health care use among survivors of adolescent and young adult cancer. Cancer.
    107. Intermittent high-dose deferoxamine for patients with iron overload and sickle cell anemia. International Journal of Pediatric Hematology/Oncology. 3:53-56.
    108. In reply [2]. Journal of Clinical Oncology. 25:3180.
    109. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1). The Lancet Oncology. 17:1396-1408.
    110. Algorithms of late effects by disease. Pediatric Oncology. 2015:1-13.
    111. In reply [2]. Journal of Clinical Oncology. 25:4690-4691.
    112. In reply [4]. Journal of Clinical Oncology. 26:162.
    113. Pulmonary effects of antineoplastic therapy. Pediatric Oncology. 2015:201-227.
    114. Pediatric hodgkin lymphoma. Hematologic Malignancies. 6:253-270.
    115. Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma. International Journal of Radiation Oncology Biology Physics. 96:943-950.
    116. In reply [10]. Journal of Clinical Oncology. 25:4860-4861.
    117. Facilitating assessment of late effects by organ system. Pediatric Oncology. 2015:15-32.
    118. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts EFS in Hodgkin Lymphoma. Pediatric Blood and Cancer.
    119. The thyroid gland. Pediatric Oncology. 2015:151-166.
    120. Special issues in pediatric Hodgkin's disease. European Journal of Haematology. 75:55-62.
    121. In reply. Journal of Clinical Oncology. 26:3104-3105.
    122. Letter to the editor. Cancer. 65:1460-1462.
    123. Pediatric hodgkin lymphoma. 253-270.
    124. Exercise and fatigue in adolescent and young adult survivors of Hodgkin lymphoma. Journal of Adolescent and Young Adult Oncology. 4:137-140.
    125. Minimal treatment of low-risk, pediatric lymphocyte-predominant hodgkin lymphoma. Journal of Clinical Oncology. 34:2372-2379.
    126. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma. Pediatric Blood and Cancer. 63:54-61.
    127. ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. Journal of the American College of Radiology. 8:302-308.
    128. To the editor (I. Cancer. 65:1462.
    SCHWARTZ's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (362)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _